Optimisation of the dibromomaleimide (DBM) platform for native antibody conjugation by accelerated post-conjugation hydrolysis. (2017)
Attributed to:
A Chemical Technology to Generate Homogeneous Antibody-Drug-Conjugates (ADCs) and Bispecifics
funded by
BBSRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1039/c7ob00220c
PubMed Identifier: 28290574
Publication URI: http://europepmc.org/abstract/MED/28290574
Type: Journal Article/Review
Volume: 15
Parent Publication: Organic & biomolecular chemistry
Issue: 14
ISSN: 1477-0520